Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria

BMC Research Notes

Obinna Onwujekwe²  Elvis Shu³  Benjamin Uzochukwu²  Rebecca O Soremekun¹  Ogochukwu C Onwujekwe⁴ 

[1] Department of Pharmacy, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria;Department of Health Administration and Management, College of Medicine, University of Nigeria Enugu-Campus, Enugu, Nigeria;Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria Enugu-Campus, Enugu, Nigeria;Department of Pharmacy, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria

关键词: Providers;    IPTp;    Chemoprophylaxis;    Chemotherapy;    Malaria in pregnancy;   

Others  :  1166469
DOI  :  10.1186/1756-0500-5-211

 received in 2011-10-28, accepted in 2012-05-02,  发布年份 2012

【 摘 要 】

Background

Malaria in pregnancy (MIP) is a major disease burden in Nigeria and has adverse consequences on the health of the mother, the foetus and the newborn. Information is required on how to improve its prevention and treatment from both the providers’ and consumers’ perspectives.

Methods

The study sites were two public and two private hospitals in Enugu, southeast Nigeria. Data was collected using a pre-tested structured questionnaire. The respondents were healthcare providers (doctors, pharmacists and nurses) providing ante-natal care (ANC) services. They consisted of 32 respondents from the public facilities and 20 from the private facilities. The questionnaire elicited information on their: knowledge about malaria, attitude, chemotherapy and chemoprophylaxis using pyrimethamine, chloroquine proguanil as well as IPTp with sulphadoxine-pyrimethamine (SP). The data was collected from May to June 2010.

Results

Not many providers recognized maternal and neonatal deaths as potential consequences of MIP. The public sector providers provided more appropriate treatment for the pregnant women, but the private sector providers found IPTp more acceptable and provided it more rationally than public sector providers (p < 0.05). It was found that 50 % of private sector providers and 25 % of public sector providers prescribed chemoprophylaxis using pyrimethamine, chloroquine and proguanil to pregnant women.

Conclusions

There is sub-optimal level of knowledge about current best practices for treatment and chemoprophylaxis for MIP especially in the private sector. Also, IPTp was hardly used in the public sector. Interventions are required to improve providers’ knowledge and practices with regards to management of MIP.

【 授权许可】

   
2012 Onwujekwe et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organisation: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. AFR/MAL/04/01. WHO, Brazzaville; 2004.
• [2]Federal Ministry of Health [FMOH]: National Antimalaria Treatment Guidelines. National Malaria and Vector Control Division, FMOH, Abuja; 2004.
• [3]World Health Organisation: The World Malaria Report. WHO, Geneva; 2009.
• [4]FMOH: National Antimalaria Treatment Guidelines. National Malaria and Vector Control Division, FMOH, Abuja; 2005.
• [5]Ruth E, Lagerberg CMN: Malaria in Pregnancy, A literature Review. J Midwifery Wom Health 2008, 53(3):209-215.
• [6]Malaria Consortium: Malaria: A Handbook for Health Professionals. Macmillian Publishers, London; 2007.
• [7]Singer B, Teklehaimanot A, Spielman A, Tozan Y, Schapira A: Coming to Grips with Malaria in the New Millennium. Earthscan, London; 2005.
• [8]Onah EH, Nkwo PO, Nwankwo OT: Malaria chemoprophylaxis during pregnancy; a survey of current practice amongst Nigerian Obstetricians. Trop J Obstet Gynaecol 2006, 23(1):17-19.
• [9]Mbaye A, Richardson K, Badejo B, Dungo S, Shulman C, Milligan P, Greenwood B, Walraven G: A randomized placebo controlled trial of intermittent preventive treatment with Sulphadoxine-Pyrimethamine in Gambian Multigravidae. Trop Med Int Health 2006, 2(7):992-1006.
• [10]Sirima SB, Sawadogo R, Moran AC, Konate A, Diarra A, Yamego M, Praise ME, Newman RD: Failure of Chloroquine chemeprophylaxis programme to adequately prevent malaria during pregnancy in Koupela Discrete, Burkina Faso. J Clin Infec Dis 2003, 36:1374-1382.
• [11]FMOH: National Guidelines and Strategies for Malaria Prevention and Control During Pregnancy. National Malaria and Vector Control Division, FMOH, Abuja; 2005.
• [12]National Population Commission (NPC) [Nigeria] and ICF Macro: Nigeria Demographic and Health Survey 2008. National Population Commission and ICF Macro, Abuja; 2009.
• [13]Lena H, Von Oertzen C, Bedu-Addo G, Holmberg V, Acquah AP, Eggelte AT, Bienzle U: Decline of placental malaria in Southern Ghana after the implementation of IPTp in pregnancy. Malar J 2007, 6:144. BioMed Central Full Text
• [14]Falade CO, Yusuf BO, Fadero FF, Mokuolu OA, Hamer DH, Salako LA: Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malar J 2007, 6:88. BioMed Central Full Text
• [15]Okonofua PE: Prevention of malaria in pregnancy, an important public health challenge. J Med Biomed Res 2004, 3(1):5-6.
• [16]Enugu State Government: Enugu State of Nigeria - The Story of Untapped Potentials. Enugu State Government, Enugu; 2001.
• [17]Wongrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH: A review of malaria diagnostic tools; microscopy and rapid diagnostic test. AmJTrop Med Hyg 2007, 77(6 Suppl):119-127.
• [18]World Health Organisation: The African Malaria Report. WHO, Geneva; 2008.
• [19]World Health Organisation: Guidelines for the Treatment of Malaria-2nd Edition. WHO, Geneva; 2010.
• [20]Anders K, Marchant T, Chambo P, Mapunda P, Reyburn H: Timing of intermittent preventive treatment for malaria in pregnancy and the implications of current policy on early uptake in north-east Tanzania. Malar J 2008, 7:79. BioMed Central Full Text
• [21]Ayoola HN, Daniel AE: Pattern of malaria presentation and treatment at Obisesan Naval Medical Centre, Lagos Nigeria. Eur J Sci Res 2009, 27:120-127.
• [22]Day N, Dondrop MA: The management of patients with severe malaria. Am J Trop Med Hygiene 2007, l77:29-35.
• [23]Kayentao K, Kodio M, Newman DR, Maiga H, Doumtable D, Ongoiba A, Coulibaly D, Keita SA, Maiga B, Mungai M, Parise EM: Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 2005, 191:109.
• [24]Akinleye SO, Falade CO, Ajayi IO: Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest. Nigeria: a cross-sectional study. BMC Pregnancy Childbirth 2009, 9:28. BioMed Central Full Text
• [25]Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy; A qualitative study of Knowledge, attitude and practices of district Health Managers, Antenatal care staff and pregnant women in Korogwe district. North-Eastern Tanzania. Mal J 2005, 4:31.